[The use of T-activin in the intensive therapy of the postoperative period in gestosis patients].
Cellular immunity and blood serum levels of parathyroid hormone have been studied in patients with gestoses depending on the disease severity. Progressive immune depression accompanied by a parallel drop in parathyroid hormone level up to critical values has been demonstrated in patients with eclampsia. The patients with pre-eclampsia were treated postoperatively with t-activin. Cellular immunity was compared in patients on and off t-activin. A marked immunostimulating effect of the drug on T-lymphocytes and especially on theophylline-resistant T-lymphocyte subpopulations has been revealed. The effect of t-activin was most marked on the 3rd-5th day of the postoperative period.
Ianiushina
V V
VV
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D003131:Combined Modality Therapy; D003422:Critical Care; D004461:Eclampsia / Q000188:drug therapy / Q000276:immunology; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D010455:Peptides / Q000627:therapeutic use*; D011182:Postoperative Care; D011225:Pre-Eclampsia / Q000188:drug therapy* / Q000276:immunology; D011247:Pregnancy; D013949:Thymus Extracts / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D010455:Peptides; D013949:Thymus Extracts; C036191:T-activin
Primenenie T-aktivina v intensivnoĭ terapii posleoperatsionnogo perioda bol'nykh gestozami.